Filing Flows › Comparisons › FENC vs DNLI
Fennec Pharmaceuticals vs Denali Therapeutics: FENC and DNLI compared
Fennec Pharmaceuticals is the larger company: $17.9M of revenue in its latest quarter (Q2 2026) against $17.8M for Denali Therapeutics (Q3 2026). Fennec Pharmaceuticals is more profitable, with an operating margin of 9.7% against -713.0%.
Where the money goes: FENC and DNLI
Fennec Pharmaceuticals (FENC) · Q2 2026
Fennec Pharmaceuticals, Q2 2026: revenue $17.9M (+85% year over year), operating margin 9.7%, net earnings $2.0M, operating cash flow $50K. The chart follows the revenue to costs, profit and cash.
Denali Therapeutics (DNLI) · Q3 2026
Denali Therapeutics, Q3 2026: revenue $17.8M, operating margin -713.0%, net earnings $70.1M, operating cash flow −$117M. The chart follows the revenue to costs, profit and cash.
| Fennec Pharmaceuticals (FENC) | Denali Therapeutics (DNLI) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $17.9M | $17.8M |
| Revenue growth, Y/Y | +85% | — |
| Operating margin | 9.7% | -713.0% |
| Net earnings | $2.0M | $70.1M |
| Net margin | 11.0% | 394.5% |
| Operating cash flow | $50K | −$117M |
Where the revenue comes from
Fennec Pharmaceuticals
- PEDMARK product sales, net: $17.2M (96%)
- Other revenue: $710K (4%)
Questions
Which is bigger, Fennec Pharmaceuticals or Denali Therapeutics?
Fennec Pharmaceuticals is the larger company: $17.9M of revenue in its latest quarter (Q2 2026) against $17.8M for Denali Therapeutics (Q3 2026).
Is Fennec Pharmaceuticals or Denali Therapeutics growing faster?
Fennec Pharmaceuticals is more profitable, with an operating margin of 9.7% against -713.0%.
More: Fennec Pharmaceuticals earnings · how Fennec Pharmaceuticals makes money · Denali Therapeutics earnings · how Denali Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.